![](/images/graphics-bg.png)
Screening of Generalized Anxiety Disorder in Patients with Epilepsy: Using a Valid and Reliable Indonesian Version of Generalized Anxiety Disorder-7 (GAD-7)
Joint Authors
Budikayanti, Astri
Larasari, Andira
Malik, Khamelia
Syeban, Zakiah
Indrawati, Luh Ari
Octaviana, Fitri
Source
Neurology Research International
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-06-02
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Introduction.
Generalized anxiety disorder (GAD) is one of the most common types of anxiety disorder in epilepsy population, comprising 21.9%, that would further impair patients’ quality of life.
Generalized Anxiety Disorder-7 (GAD-7) is the only screening tool for GAD that has been validated in patients with epilepsy (PWE).
It is a self-reporting instrument that can be completed in less than three minutes; hence, its usage is appropriate in primary healthcare and neurology outpatient clinic.
This study aimed to obtain a valid and reliable Indonesian version of GAD-7, assess its accuracy, and finally evaluate the prevalence of GAD in Indonesian PWE along with its contributing factors.
Methods.
A cross-sectional study was conducted in Cipto Mangunkusumo General Hospital, Jakarta.
The GAD-7 was translated and adapted using World Health Organization (WHO) steps.
Validity, reliability, test-retest reliability, and diagnostic accuracy were evaluated.
Then, epilepsy outpatients were screened for GAD using the Indonesian version of GAD-7.
Results.
Internal validity and reliability for Indonesian version of GAD-7 were satisfactory with validity coefficient of 0.648 to 0.800 (p<0.01) and Cronbach’s alpha value of 0.867.
The best cutoff value to detect GAD in Indonesian PWE was >6 with the sensitivity, specificity, negative predictive value, and positive predictive value of 100%, 84.4%, 100%, and 55.8%, respectively.
ROC analysis showed the area under the curve of 0.98 (95% CI: 0.96–0.99).
The total subjects screened with the validated Indonesian version of GAD-7 were 146, and 49% were screened as having GAD.
Sociodemographic and clinical characteristics had no statistically significant association with the presence of GAD.
Conclusion.
The Indonesian version of GAD-7 was a valuable screening tool to detect GAD in PWE.
GAD was screened in a quite high proportion of PWE.
Sociodemographic and clinical characteristics were not proven to play role in its development.
American Psychological Association (APA)
Budikayanti, Astri& Larasari, Andira& Malik, Khamelia& Syeban, Zakiah& Indrawati, Luh Ari& Octaviana, Fitri. 2019. Screening of Generalized Anxiety Disorder in Patients with Epilepsy: Using a Valid and Reliable Indonesian Version of Generalized Anxiety Disorder-7 (GAD-7). Neurology Research International،Vol. 2019, no. 2019, pp.1-10.
https://search.emarefa.net/detail/BIM-1201746
Modern Language Association (MLA)
Budikayanti, Astri…[et al.]. Screening of Generalized Anxiety Disorder in Patients with Epilepsy: Using a Valid and Reliable Indonesian Version of Generalized Anxiety Disorder-7 (GAD-7). Neurology Research International No. 2019 (2019), pp.1-10.
https://search.emarefa.net/detail/BIM-1201746
American Medical Association (AMA)
Budikayanti, Astri& Larasari, Andira& Malik, Khamelia& Syeban, Zakiah& Indrawati, Luh Ari& Octaviana, Fitri. Screening of Generalized Anxiety Disorder in Patients with Epilepsy: Using a Valid and Reliable Indonesian Version of Generalized Anxiety Disorder-7 (GAD-7). Neurology Research International. 2019. Vol. 2019, no. 2019, pp.1-10.
https://search.emarefa.net/detail/BIM-1201746
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1201746